Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02073734 · ClinicalTrials.gov registry record · Phase 3

Effects of Preoperative Dexamethasone Study on QOL After Vaginal Reconstructive Surgery for POP

A Phase 3 study of Pelvic Organ Prolapse and PONV, sponsored by TriHealth.

Completed
Registry status
Phase 3
Development phase
63
Enrollment target
1
Study location

NCT02073734 is a Phase 3 study of Pelvic Organ Prolapse and PONV that has completed, run by TriHealth. The registered enrollment target is 63 participants, below the 144-participant average among 40 other Pelvic Organ Prolapse trials with a reported enrollment target (56% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02073734, a Phase 3 study of Pelvic Organ Prolapse and PONV, has completed, sponsored by TriHealth.

COMPLETED
Registry status
Phase 3
Development phase
63 participants
Enrollment target
1
Study location

Study Summary

The investigators hypothesize that preoperative administration of 8 mg IV dexamethasone will benefit patients' perceived quality of recovery after surgery.

Interventions

  • DRUG Placebo
  • DRUG Dexamethasone

Study Locations (1)

Ohio

  • Triheath - Cincinnati

Trial Details

FieldValue
Enrollment Target 63 participants
Start Date 2013-02
Est. Completion 2014-08
Phase Phase 3

Sponsor

TriHealth

81 total trials

What the Registry Record Tells You About NCT02073734

The ClinicalTrials.gov registry entry for NCT02073734 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 63 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 144-participant average among 40 other Pelvic Organ Prolapse trials with a reported enrollment target (56% lower). The listed sponsor is TriHealth, which has 81 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Pelvic Organ Prolapse appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT02073734 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.

Frequently Asked Questions

What is clinical trial NCT02073734 about?

NCT02073734 is a clinical study titled "Effects of Preoperative Dexamethasone Study on QOL After Vaginal Reconstructive Surgery for POP". The investigators hypothesize that preoperative administration of 8 mg IV dexamethasone will benefit patients' perceived quality of recovery after surgery.

What is the current status of trial NCT02073734?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 63 participants. The study started on 2013-02. Estimated completion is 2014-08.

What conditions does trial NCT02073734 study?

This clinical trial studies the following conditions: Pelvic Organ Prolapse, PONV.

What interventions are being tested in trial NCT02073734?

The interventions under investigation include: Placebo (DRUG), Dexamethasone (DRUG).

Who is sponsoring clinical trial NCT02073734?

This trial is sponsored by TriHealth, which has 81 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02073734 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pelvic Organ Prolapse

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.